Carter’s, Inc. (NYSE:CRI) reported third-quarter adjusted earnings on Monday that came in slightly ahead of expectations, but ...
Carter’s third quarter performance drew a positive market response, despite missing Wall Street’s revenue expectations and ...
Carter's (CRI) shares saw some modest movement today, giving investors a small uptick in early trading. The company’s recent performance has invited fresh attention to its valuation, especially as ...
Analysts expect the Atlanta, Georgia-based company to report quarterly earnings at 74 cents per share, down from $1.64 per ...
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares dropped 43% to $14.71 after the company announced it is temporarily halting ...
Carter’s, Inc.’s board of directors has adopted a shareholder rights plan, also known as a poison pill, following an investment firm’s “rapid accumulation of a significant amount” of its common stock, ...
Carter's Inc. (CRI) on Monday reported profit of $11.6 million in its third quarter. On a per-share basis, the Atlanta-based company said it had profit of 32 cents.